当前位置: 首页 > 期刊 > 《中国医学创新》 > 2014年第12期 > 正文
编号:12707126
维生素D受体基因多态性与慢性乙型肝炎患者的关联研究(3)
http://www.100md.com 2014年4月25日 刘蒙 赵龙凤
第1页

    参见附件。

     [10] Sneha J, Luiz-Carlos P, Liu X K, et al. 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A.[J]Mol Cell Biol, 2011, 31(17): 3653-3669.

    [11] Holick M F. Evolution and function of vitamin D[J].Recent Results Cancer Res, 2003, 164(12): 3-28.

    [12] Matilainen J M, Malinen M, Turunen M M, et al. The number of vitamin D receptor binding sites defines the different vitamin D responsiveness of the CYP24 gene in malignant and normal mammary cells[J]. Biol Chem, 2010, 285(10): 24 174-24 183.

    [13] Ghiringhelli F, Puig P E, Roux S, et al. Tumor cellsconvert immature myeloid dendritic cells into TGF-betasecretingcells inducing CD4+CD25+ regulatory T cell proliferation[J].J Exp Med, 2005, 202(7): 919-929.

    [14] Huang B, Pan P Y, LI Q, et al. Gr-1+CD115+ immaturemyeloid suppressor cells mediate the development of tumorinduced T regulatory cells and T-cell anergy in tumor-bearing host[J]. Cancer Res, 2006, 66(2): 1123-1131.

    [15] Arai H, Miyamoto K, Taketani Y, et al. A vitamin D receptor genepolymorphism in the translation initiation codeon: Effect on protein activity and relation to bone mineral density in Japaneses women[J]. J Bone Miner Res, 1997, 12(6): 915-921.

    [16]韩世发.阿德福韦酯联合复方虫草散剂治疗慢性乙型肝炎的临床观察[J].中国现代医生,2010,48(21):113-115.

    (收稿日期:2014-01-26) (本文编辑:黄新珍)

您现在查看是摘要介绍页,详见PDF附件